Aveanna Healthcare (NASDAQ:AVAH) Upgraded by Barclays to "Overweight" Rating

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Barclays upgraded shares of Aveanna Healthcare (NASDAQ:AVAH - Free Report) from an equal weight rating to an overweight rating in a report published on Tuesday morning, MarketBeat Ratings reports. Barclays currently has $9.50 target price on the stock, up from their prior target price of $5.50.

AVAH has been the topic of a number of other research reports. Truist Financial dropped their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Raymond James Financial raised shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 price objective on the stock in a research report on Monday, August 11th. UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and boosted their target price for the company from $6.75 to $8.00 in a research report on Tuesday. Wall Street Zen upgraded Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Finally, Jefferies Financial Group raised Aveanna Healthcare from a "hold" rating to a "buy" rating and reduced their price objective for the company from $6.25 to $6.00 in a research note on Monday, July 21st. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $7.50.

Aveanna Healthcare Stock Up 6.1%

Aveanna Healthcare stock traded up $0.43 during trading hours on Tuesday, reaching $7.47. 1,547,703 shares of the company's stock were exchanged, compared to its average volume of 1,739,328. The firm's 50 day simple moving average is $4.92 and its 200 day simple moving average is $4.94. Aveanna Healthcare has a twelve month low of $3.67 and a twelve month high of $7.69. The firm has a market capitalization of $1.56 billion, a PE ratio of 27.08 and a beta of 1.95.

Insiders Place Their Bets

In related news, CAO Deborah Stewart sold 15,457 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $5.56, for a total value of $85,940.92. Following the transaction, the chief accounting officer owned 285,396 shares of the company's stock, valued at approximately $1,586,801.76. This trade represents a 5.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the transaction, the insider directly owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. The trade was a 2.53% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,295,145 shares of company stock worth $11,941,141 in the last 90 days. Company insiders own 7.80% of the company's stock.

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare in the 1st quarter valued at about $25,000. BNP Paribas Financial Markets purchased a new stake in Aveanna Healthcare in the 4th quarter valued at about $35,000. Tower Research Capital LLC TRC increased its stake in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after buying an additional 6,854 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare in the 2nd quarter valued at about $43,000. Finally, Diversified Trust Co purchased a new stake in Aveanna Healthcare in the 2nd quarter valued at about $57,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.